Although 2022 saw a general decline in M&A activity in the life sciences industry compared to 2021’s frenetic pace (when deal volume was up 52% from 2020), life sciences deal flow in 2022 on balance remained strong despite...more
General trends in life sciences M&A Although the COVID-19 pandemic that defined 2020 continued to shape much of the life sciences industry in 2021, the way that it did was markedly different. While 2020’s M&A landscape was...more
1. Experienced advisors -
Choose experienced advisors, including lawyers, auditors and financial consultants (if necessary), and get them involved early. Advisors who work routinely with the SEC and investment bankers –...more
11/1/2019
/ Accounting ,
Acquisitions ,
Auditors ,
Board of Directors ,
Corporate Governance ,
Cybersecurity ,
Direct Listing ,
Due Diligence ,
Executive Compensation ,
Financial Statements ,
Initial Public Offering (IPO) ,
Internal Controls ,
Investment Banks ,
Lock-Up Agreement ,
Securities and Exchange Commission (SEC)